GSK

GSK ESMO
Biotech

GSK says 'stay tuned' for more ADC data as Hansoh posts 49% ORR

GSK may be happy with the latest Hansoh readouts, but the Big Pharma’s oncology R&D chief told Fierce to “stay tuned” for the company’s own data.
James Waldron Oct 19, 2025 10:40am
ChatGPT said Low-poly magenta liver model centered on a pale blue background patterned with sketchy dollar signs suggestin
Favicon Fierce Pharma

Big Pharma bets big on MASH with a new combo playbook

Oct 17, 2025 9:30am
abstract concept of woman or girl

As 2 CEOs depart, life sciences face leadership void for women

Oct 3, 2025 11:22am
Parachute over a mountain in Switzerland

GSK chief steps down in stunning move—Chutes & Ladders

Oct 3, 2025 8:30am
Walmsley
Favicon Fierce Pharma

GSK's Emma Walmsley to step down as CEO in shock move

Sep 29, 2025 3:39am
GSK
Favicon Fierce Pharma

GSK plots $30B investment in US manufacturing, R&D

Sep 16, 2025 7:01pm